Home › Stocks › BCLI › All Fund Holders
BCLI — BRAINSTORM CELL THERAPEUTICS · All Fund Holders
Funds holding (latest): 22 · Reported value held: $478.08K
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Marshall Wace history | Q2 2023 | 67.42K | $138.88K | 0.00% | New |
| Geode Capital Management history | Q2 2025 | 54.58K | $61.14K | 0.00% | Reduce |
| Goldman Sachs Group history | Q3 2021 | 17.60K | $58.00K | 0.00% | New |
| Moore Capital Management history | Q3 2023 | 200.00K | $40.02K | 0.00% | Hold |
| Millennium Management history | Q3 2023 | 175.50K | $35.12K | 0.00% | Add |
| Vanguard Group history | Q2 2025 | 27.72K | $31.05K | 0.00% | Hold |
| BlackRock Inc history | Q2 2025 | 25.17K | $28.19K | 0.00% | Hold |
| Northern Trust Corp history | Q3 2024 | 112.36K | $25.88K | 0.00% | Hold |
| Two Sigma Investments history | Q3 2023 | 77.18K | $15.44K | 0.00% | Add |
| UBS Group AG history | Q2 2025 | 12.38K | $13.87K | 0.00% | Add |
| Citadel Advisors history | Q3 2024 | 40.40K | $9.30K | 0.00% | Reduce |
| Deutsche Bank AG history | Q3 2021 | 2.10K | $7.00K | 0.00% | New |
| Morgan Stanley history | Q2 2025 | 5.80K | $6.50K | 0.00% | Add |
| BNY Mellon history | Q3 2024 | 11.99K | $2.76K | 0.00% | Hold |
| Charles Schwab Investment Management history | Q3 2023 | 11.29K | $2.26K | 0.00% | Hold |
| Wells Fargo & Co history | Q2 2025 | 1.34K | $1.50K | 0.00% | Hold |
| Citigroup Inc history | Q2 2025 | 663 | $743 | 0.00% | New |
| JPMorgan Chase & Co history | Q1 2025 | 171 | $215 | 0.00% | Add |
| Bank of America Corp history | Q2 2025 | 136 | $152 | 0.00% | Add |
| Renaissance Technologies history | Q3 2023 | 203.60K | $41 | 0.00% | Reduce |
| T. Rowe Price Associates history | Q3 2023 | 41.70K | $9 | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2025 | 6 | $7 | 0.00% | Reduce |